Atlas Health, a private equity fund established to invest in European Healthcare companies, has held an oversubscribed final close of its debut fund, Atlas Health Fund I, at its £400m (US$541m) hard cap.
Atlas, a specialist healthcare platform built around deep sector insight, a differentiated sourcing engine, and a highly experienced team with a clear, repeatable playbook across MedTech, Niche Pharma and Animal Health, aims to invest £25m-100m of equity in each portfolio company, and recycle the profits from its investments into a philanthropic foundation.
FirstPoint Equity, a private capital advisory firm, acted as exclusive placement agent for Atlas Health Fund I. The fundraise was completed in just four months and secured commitments from a high-quality, diversified base of institutional investors across multiple geographies.
